Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2582-8185 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

A concise review on analytical profile of Vigabatrin

Breadcrumb

  • Home
  • A concise review on analytical profile of Vigabatrin

Vikas R. Patil 1, *, Vinay V. Sarode 2, Yogesh A. Chaudhari 3, Sudhir G. Patil 3, Samir B. Tadavi 3 and Rohit S. Patil 3

1 Department of Pharmaceutical Chemistry, Smt. Sharadchandrika Suresh Patil College of Pharmacy, Chopda, Maharashtra, India.
2 Department of Pharmacology, VYWS, Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha 442001, India.
3 Department of Pharmaceutics, Smt. Sharadchandrika Suresh Patil College of Pharmacy, Chopda, Maharashtra, India.
 
Review Article
World Journal of Advanced Research and Reviews, 2023, 17(02), 061–067
Article DOI: 10.30574/wjarr.2023.17.2.0178
DOI url: https://doi.org/10.30574/wjarr.2023.17.2.0178
 
Received on 19 December 2022; revised on 29 January 2023; accepted on 01 February 2023
 
Vigabatrin (VGB) is a drug of Anticonvulsant class. It works by decreasing abnormal electrical activity in the brain. It inhibits the GABA-degrading enzyme i.e. GABA transaminase, it increases the GABA concentrations in the brain. Vigabatrin is used for the treatment of refractory complex partial seizures in adults and also used for children 2 years of age and older and infantile spasms in children. Vigabatrin was approved for anticonvulsant medication by USFDA on August 21, 2009. Therefore, in the present review article, we have enlisted different analytical method such as Ultraviolet (UV) visible spectroscopy, High-performance liquid chromatography (HPLC), Ultra-performance liquid chromatography (UPLC) and Gas Chromatography for both qualitative and quantitative analysis of VGB in pharmaceutical and biological. In the future, this review article will assist researchers regarding the development of a new analytical method for VGB.
 
Vigabatrin; Anticonvulsant; USFDA; Analytical Method; HPLC; Bioanalytical Method
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2023-0178.pdf

Preview Article PDF

Vikas R. Patil, Vinay V. Sarode, Yogesh A. Chaudhari, Sudhir G. Patil, Samir B. Tadavi and Rohit S. Patil. A concise review on analytical profile of Vigabatrin. World Journal of Advanced Research and Reviews, 2023, 17(2), 061-067. Article DOI: https://doi.org/10.30574/wjarr.2023.17.2.0178

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 International Journal of Science and Research Archive - All rights reserved

Developed & Designed by VS Infosolution